Literature DB >> 29843130

Depletion of Cholesterol Reduces ENaC Activity by Decreasing Phosphatidylinositol-4,5-Bisphosphate in Microvilli.

Yu-Jia Zhai1,2, Bing-Chen Liu1,2, Shi-Peng Wei2, Chu-Fang Chou3, Ming-Ming Wu2,4, Bin-Lin Song2,4, Valerie A Linck2, Li Zou2, Shuai Zhang2, Xue-Qi Li1, Zhi-Ren Zhang4, He-Ping Ma2.   

Abstract

BACKGROUND/AIMS: The epithelial sodium channel (ENaC) in cortical collecting duct (CCD) principal cells plays a critical role in regulating systemic blood pressure. We have previously shown that cholesterol (Cho) in the apical cell membrane regulates ENaC; however, the underlying mechanism remains unclear.
METHODS: Patch-clamp technique and confocal microscopy were used to evaluate ENaC activity and density.
RESULTS: Here we show that extraction of membrane Cho with methyl-β-cyclodextrin (MβCD) significantly reduced amiloride-sensitive current and ENaC single-channel activity. The effects were reproduced by inhibition of Cho synthesis in the cells with lovastatin. We have previously shown that phosphatidylinositol-4,5-bisphosphate (PIP2), an ENaC activator, is predominantly located in the microvilli, a specialized apical membrane domain. Here, our confocal microscopy data show that α-ENaC was co-localized with PIP2 in the microvilli and that Cho was also co-localized with PIP2 in the microvilli. Either extraction of Cho with MβCD or inhibition of Cho synthesis with lovastatin consistently reduced the levels of Cho, PIP2, and ENaC in the microvilli.
CONCLUSIONS: Since PIP2 can directly stimulate ENaC and also affect ENaC trafficking, these data suggest that depletion of Cho reduces ENaC apical density and activity at least in part by decreasing PIP2 in the microvilli.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Confocal microscopy; ENaC; Lovastatin; Methyl-β-cyclodextrin; PIP2; Patch-clamp technique

Mesh:

Substances:

Year:  2018        PMID: 29843130     DOI: 10.1159/000490170

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  4 in total

1.  Lovastatin attenuates hypertension induced by renal tubule-specific knockout of ATP-binding cassette transporter A1, by inhibiting epithelial sodium channels.

Authors:  Ming-Ming Wu; Chen Liang; Xiao-Di Yu; Bin-Lin Song; Qiang Yue; Yu-Jia Zhai; Valerie Linck; Yong-Xu Cai; Na Niu; Xu Yang; Bao-Long Zhang; Qiu-Shi Wang; Li Zou; Shuai Zhang; Tiffany L Thai; Jing Ma; Roy L Sutliff; Zhi-Ren Zhang; He-Ping Ma
Journal:  Br J Pharmacol       Date:  2019-07-30       Impact factor: 8.739

Review 2.  Regulating ENaC's gate.

Authors:  Thomas R Kleyman; Douglas C Eaton
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-13       Impact factor: 4.249

3.  Cholesterol Stimulates the Transient Receptor Potential Melastatin 4 Channel in mpkCCDc14 Cells.

Authors:  Yong-Xu Cai; Bao-Long Zhang; Miao Yu; Yan-Chao Yang; Xue Ao; Di Zhu; Qiu-Shi Wang; Jie Lou; Chen Liang; Liang-Liang Tang; Ming-Ming Wu; Zhi-Ren Zhang; He-Ping Ma
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

4.  Alteration of Membrane Cholesterol Content Plays a Key Role in Regulation of Cystic Fibrosis Transmembrane Conductance Regulator Channel Activity.

Authors:  Guiying Cui; Kirsten A Cottrill; Kerry M Strickland; Sarah A Mashburn; Michael Koval; Nael A McCarty
Journal:  Front Physiol       Date:  2021-06-07       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.